more severe phenotype which could indicate a partial overlap of his deletion with the middle 6q interval. The phenotypes of both patients could be partly correlated with the gene content of their deletions and with phenotypes of other published patients. Copyright © 2011 S. Karger AG, Basel Three different phenotypic groups have been suggested in carriers of interstitial 6q deletions according to the location of the defect: proximal deletions (6q11q16) with upslanted fissures, thin lips, and hernias; middle deletions (6q15q25) with microcephaly, hypertelorism, intrauterine growth retardation, respiratory problems, and limb malformations; and distal deletions (6q25qter) with cleft palate, retinal abnormalities, genital hypoplasia, and seizures [Hopkin et al., 1997] . Hypotonia, ear and facial dysmorphism, and mental retardation are common to all 3 groups [Hopkin et al., 1997] . However, most of the older studies were based solely on karyotyping, and the size and location of the deletions were determined only at low resolution. The recent boom of microarray methods allows fine mapping of the deletion breakpoints and a much more precise delineation of the extent and gene content
of the aberrations which in turn allows better genotypephenotype correlations. In addition, molecular analysis of the deletion breakpoints can shed light on the aberration mechanisms. We present 2 patients with proximal 6q deletions identified using karyotyping. Detailed analysis of the deletions showed that they subdivided the proximal 6q region into 2 parts of similar size. One of the deletions involved the centromere and arose most likely through the centromere fission mechanism, while the second deletion was probably caused by non-homologous end joining. The patients had remarkably different phenotypes which could be partly correlated with the gene content of their deletions and with phenotypes of other patients with proximal 6q deletions.
Materials and Methods

Case Report
Patient 1 was the second child of healthy unrelated parents. The age of the mother and father was 41 and 45 years, respectively. The pregnancy was uneventful. Cytogenetic analysis of amniotic fluid cells performed due to advanced maternal age showed an apparently normal female karyotype. The delivery was at the 31st week of gestation by Caesarean section due to breech and fetal distress. The birth weight of the girl was 1,740 g ( 1 75th centile) and length was 44 cm ( 1 75th centile). The neonatal period was unremarkable. At the age of 2 months she developed hypotonia and affective paroxysms. EEG showed an abnormal pattern, and subsequent MRI proved delayed myelinization and bilateral frontal lobe atrophy, but no other major anomalies. The girl was referred to a geneticist at the age of 3 years because of developmental delay and absent speech. She had mild facial dysmorphism (high forehead, hypertelorism, epicanthal folds, dysplastic ears), single palmar crease on the right hand, pectus excavatum, hypotonia, and mild mental retardation. The audiologic exam was normal.
Patient 2 was the first child of healthy unrelated 30-year-old parents. Fetal ultrasound showed a heart defect and cleft palate. Prenatal karyotype was 46,XY,?del(6)(q?). During the third trimester, polyhydramnion occurred. The boy was born at the 40th week of gestation by spontaneous delivery. His weight was 3,390 g ( 1 50th centile) and length was 53 cm ( 1 95th centile). He suffered from a congenital heart defect (common atrium), cleft palate, and diaphragmatic hernia. Facial dysmorphism (low forehead, epicanthal folds, prominent eyelids, broad nasal tip, anteverted flared nostrils, long philtrum, micrognathia, dysplastic ears), atypical dermatoglyphs, micropenis, and cryptorchidism were also present. On examination at the age of 8 months his length was 74 cm ( 1 50th centile), weight was 8,720 g (25th centile), and head circumference was 48 cm (95th centile). The boy suffered from developmental delay, seizures, laryngomalacia, bilateral iris coloboma and optic disc hypoplasia, and showed hypermobility of joints. EEG proved focal epilepsy, and CT scan showed global atrophy of the brain, partial agenesis of corpus callosum, and dilatation of the ventricles.
Karyotyping, Array CGH, mBAND, FISH, and Molecular Analysis of the Breakpoints
Cytogenetic analysis of blood lymphocytes was performed using standard protocols. mBAND analysis with the XCyte6 probe (MetaSystems, Altlußheim, Germany) was used for fine assessment of the deletions in both patients. Chromosome 6 painting probe WCP6 (Cambio, Cambridge, UK) was used to exclude a balanced insertional translocation in the parents of patient 2. FISH analysis of patient 1 and her mother was performed with chromosome 6 centromeric probe D6Z1 (Cytocell, Cambridge, UK). Genomic DNA was isolated from blood using Gentra Puregene Blood Kit (Qiagen, Hilden, Germany). Custom array CGH analysis was performed by Nimblegen on the catalogue array HG18_ CHR6_FT with median probe spacing of 404 bp, and the results were analysed using SignalMap (Nimblegen, Madison, Wisc., USA). Long-range PCR (LR-PCR) used the Expand Long Template PCR System (Roche, Basel, Switzerland). The primer sequences are available on request. PCR fragments were purified using QIAamp PCR Purification Kit (Qiagen) and sequenced on an ABI PRISM 3100 automatic sequencer (Applied Biosystems, Foster City, Calif., USA). Bioinformatic analysis used the hg18 human genome assembly available in the UCSC Genome Browser (http://genome.ucsc.edu/cgi-bin/hgGateway).
Results
Karyotyping of patient 1 showed a small deletion of 6q11q13. Array CGH mapped the proximal deletion breakpoint to the centromere genome assembly gap (chr 6 Mb 58.89-61.94). The distal breakpoint mapped around Mb 76.55. The total size of the deleted region was ϳ 15 Mb ( fig. 1 ). It contained 34 protein-coding RefSeq genes. The unaffected mother of patient 1 carried a mosaic karyo- type with the same deletion in all metaphases analysed and, in addition, a small supernumerary marker in 77% of cells, probably a ring chromosome. mBAND analysis confirmed that the marker chromosome constituted of proximal 6q material deleted from the derived chromosome 6 ( fig. 2 A) . Postnatal cytogenetic analysis of patient 2 revealed a deletion of 6q14q16, and mBAND analysis confirmed the result of the karyotyping ( fig. 2 B) . Chromosome painting excluded a balanced insertional translocation in both parents who had normal karyotypes. Array CGH analysis of patient 2 indicated that the deletion affected chromosome 6 between Mb 77.23-96.63. The length of the deletion was ϳ 19.5 Mb ( fig. 1 ). The deleted region contained 58 protein-coding RefSeq genes.
FISH analysis of the mother of patient 1 with the chromosome 6 centromeric probe showed in all cells analysed a significantly weaker signal from the derivative chromosome 6 compared to the normal homologue, and a weak signal was also present on the marker chromosome ( fig. 2 C) . However, the signals from the normal and deleted chromosome 6 homologues of patient 1 were of similar intensity ( fig. 2 D) .
Fine mapping of the distal deletion breakpoint in patient 1 was a prerequisite for the intended cloning of the proximal breakpoint using inverse PCR. Array CGH suggested that the distal breakpoint mapped to intron 1 of the MYO6 gene, within a 3.5-kb DNA stretch proximal to nucleotide 76, 555, 196 . Sequence analysis of a series of PCR products of genomic DNA spanning known SNPs and/or possible STRs showed that patient 1 was heterozygous for SNP rs2748963 (G/T) at nucleotide 76,559,033 while all markers in the 10.5-kb interval proximal to this SNP were non-informative (homo-or hemizygous). Heterozygosity for SNP rs2748963 was retained in LR-PCR products extending to nucleotide 76,554,600. This nucleotide was located at the distal end of a 3-kb long contiguous cluster of various Alu and L1 repeats ( fig. 3 ). This information together with the array data indicated that the distal deletion breakpoint in patient 1 was most likely located within this repetitive element cluster, precluding the use of inverse PCR for cloning of the proximal breakpoint located in the centromeric heterochromatin.
In patient 2 the proximal breakpoint mapped between the IMPG1 and HTR1B genes, and the distal breakpoint was located in intron 1 of FUT9 . The deletion junction was bridged with a LR-PCR product. Sequencing of this DNA fragment showed that the deletion joined nucleotides 77,231,427 and 96,635,141, with 7 nucleotides not belonging to any of the breakpoints added at the junction ( fig. 3 ) . No low copy repeats or dispersed repetitive elements were involved in the breakpoints, and their sequences had no homology ( fig. 3 ).
Discussion
To our knowledge, 20 patients with deletions affecting the proximal 6q region and possibly extending to the adjacent part of middle 6q have been analyzed using array CGH and described in the literature [Le Caignec et al., 2005; Klein et al., 2007; Bonaglia et al., 2008; Derwinska et al., 2009; Lespinasse et al., 2009; Traylor et al., 2009; Wang et al., 2009; Spreiz et al., 2010; Woo et al., 2010] or the Decipher database [Firth et al., 2009] ( fig. 4 ) . Most of these patients were analysed using low-resolution arrays, and in none of them an attempt was made to clone the , and FISH analysis of chromosome 6 centromere in the mother of patient 1 ( C ) and in patient 1 ( D ). The mBAND analyses showed small deletions of proximal 6q (arrows) in both cases ( A , B ). The marker chromosome in the mother of patient 1 consisted of proximal 6q material deleted from the derived chromosome 6 ( A ). The signals of the chromosome 6 centromeric probe were present both on the deleted homologue and the marker (2 signals may suggest a double ring chromosome) in the mother of patient 1, and the signal on the deleted homologue was weaker than that on the normal chromosome 6 ( C ). In patient 1 no difference in signal intensity could be observed ( D ).
deletion breakpoints and to elucidate the mechanisms of the aberrations. The aberration in the mother of our patient 1 was likely caused by centromere fission. This mechanism of parallel formation of a deleted chromosome and a marker, most often a ring chromosome derived from the deleted material, was proposed by Barbara McClintock in 1938 and recently suggested to be referred to by her name [Baldwin et al., 2008] . The marker probably compensated for the deletion and caused the normal phenotype of the mother. However, due to its likely ring structure and the inherent instability of rings [Kosztolanyi, 1987] , this marker was present only in a mosaic state, and was not transmitted or was lost in the early development of patient 1. About a dozen of patients who inherited an unbalanced karyotype from a parent with a balanced constitu- Fig. 4 . Alignment of deletions in patients 1 and 2 with published deletions. Only patients with deletions not associated with other rearrangements, fine mapped using array methods and overlapping with but not extending significantly the region covered by deletions in our patients, were included. The ideogram on top shows the classification of 6q deletions. Fig. 3 . Repeats at the distal deletion breakpoint in patient 1 and repeat content and sequence of both breakpoints in patient 2. LINE repeats in the 3.5-kb regions around the breakpoints are drawn on the line, SINE repeats above and other repeats below the line. In patient 1 (with the proximal breakpoint in the centromere gap), the distal breakpoint could be mapped only approximately to a cluster of repeats (red horizontal double arrow). The gray arrow marks the position very likely to be singlecopy based on the array CGH data. The right black arrow points to heterozygous SNP rs2748963, and heterozygosity was retained on LR-PCR products extending to the position marked by the left black arrow. In patient 2 both the proximal (blue arrows) and distal breakpoints (green arrows) were located in repeat-poor regions. DNA sequencing showed that 7 bases were added at the junction. The deleted sequence is in lowercase.
tion involving centromere misdivision have been described [reviewed in Burnside et al., 2011] . Interestingly, while in the mother the centromeric signal from the deleted chromosome 6 was significantly weaker than that from the normal homologue, possibly reflecting the centromere fission, both chromosomes 6 in patient 1 showed signals of equal intensity, which could indicate some kind of healing or regaining of the centromeric alpha satellite arrays on the deleted chromosome. This and the absence of any new constriction on the deleted chromosome suggests that in this case the amount of the alpha satellite material retained on the deleted chromosome was sufficient to support the centromere function. This contrasted with a recently published similar event on chromosome 8 which, however, resulted in neocentromere formation [Burnside et al., 2011] .
The distal deletion breakpoint in patient 1 likely involved a dense cluster of dispersed repeats rich in transposable sequences which precluded the cloning of the deletion junction. Interestingly, LINEs and SINEs are known to be present at increased frequency in the arrays of the centromeric alpha satellite repeats [Ugarkovic, 2009] , and thus non-allelic homologous recombination may have played a role in the formation of this aberration [Lupski and Stankiewicz, 2005] . On the contrary, the absence of homology and different repeat content in the vicinity of the deletion breakpoints in patient 2 argued against non-allelic homologous recombination as the mechanism causing the aberration. The presence of 7 newly added bases at the deletion junction could be a signature of non-template directed repair associated with non-homologous end joining [Lupski and Stankiewicz, 2005] .
The deletions in our 2 patients did not overlap and subdivided the proximal 6q region into 2 parts of almost equal length ( fig. 4 ) . The phenotypic abnormalities in our patients were of remarkably different severity. While the phenotype of patient 1 was relatively mild compared to the previously published cases and patient 2, the phenotype of patient 2 was more severe than that of other patients with proximal 6q deletions. Major anomalies were more often described in patients with middle or distal 6q deletions [Hopkin et al., 1997] . As the boundary between the proximal and middle 6q deletions was not exactly defined [Hopkin et al., 1997] , the deletion in patient 2 might overlap with the region of the middle deletions.
The deletion of the distal part of proximal 6q in patient 2 may had more severe consequences due to the higher gene density in this region. Although the deletions in patients 1 and 2 were of similar size, the number of genes deleted in patient 2 was almost a double of that in patient 1. Both deletions were too large and with too many genes to allow assigning of individual symptoms to specific genes. Neither of our patients showed symptoms of recessive disorders caused by genes located in the region ( EYS , LMBRD1, and SLC17A5 in patient 1, and LCA5 , BCKDHB , SLC35A1, and RARS2 in patient 2) indicating lack of mutations on the remaining alleles of these genes. Interestingly, at the age when they were last examined, the patients also did not show any recognizable symptoms of dominant disorders mapping to the deletions: multiple epiphyseal dysplasia type 6 (COL9A1) [CzarnyRatajczak et al., 2001 ], cone-rod dystrophy type 7 (RIMS1) [Johnson et al., 2003] , and autosomal dominant nonsyndromic sensorineural hearing loss (MYO6) [Melchionda et al., 2001] in patient 1, and autosomal dominant atrophic macular degeneration (ELOVL4) [Bernstein et al., 2001; Zhang et al., 2001 ] in patient 2. The disorders can have a later onset, but other published deletion cases also showed no symptoms, indicating that these disorders may result from gain-of-deleterious-function mutations, although truncating mutations have also been described in at least some of them [Bernstein et al., 2001; Melchionda et al., 2001; Zhang et al., 2001] . Multiple genes in both deletions were good candidates for the developmental delay and mental retardation observed in both patients (e.g. KHDRBS2 , BAI3 , B3GAT2 , KCNQ5, and FILIP1 in patient 1, and HTR1B , ORC3L , GABRR1 , GABRR2, and EPHA7 in patient 2).
Some of the genotype-phenotype correlations were contradictory. A study of a small deletion involving only 2 genes suggested that the defect of EPHA7 could negatively affect brain size and shape and lead to microcephaly. However, microcephaly was not observable in all patients with deletions overlapping the EPHA7 locus [Traylor et al., 2009] , and patient 2, who also has the EPHA7 gene deleted, rather showed macrocephaly. This implies that some symptoms may be masked by the general population variability, and/or that the effect of some genes can be overridden by the effects of other loci deleted together with the specific gene.
Alignment of individual symptoms observed in our patients and other deletion carriers described in the literature indicated that hydronephrosis and other urinary tract defects might be enriched in patients with deletions overlapping middle 6q13, and similarly other symptoms could be assigned to deletions of other subregions (joint laxity and umbilical hernia to 6q14.1, cleft palate to 6q15, and various eye problems to 6q16.1). Similarly, while macrostomia was prevailing in patients with deletions of the proximal part of the region studied, microstomia was characteristic for the distal part; and the same applied to upslanting and downslanting palpebral fissures. No obvious candidate genes for these phenotypes could be identified in these regions. Obesity could be characteristic for defects in the SIM1 gene in the Prader-Willi-like candidate region of 6q16 [Bonaglia et al., 2008] , which is distal to the region deleted in our patient 2. However, careful alignment of the published phenotypes also showed that the patients often clustered according to the author of the report rather than the chromosome region deleted, further stressing the importance of standardized phenotyping.
It can be expected that the widespread use of microarray and next-generation sequencing technologies will lead to the identification of small aberrations in patients with less complex phenotypes, which will be more informative for the correlation of individual symptoms with specific genes in the proximal 6q region.
